Investing.com -- iSpecimen Inc. (NASDAQ:ISPC)股价下跌7.7%，此前这家生物样本市场宣布以每股0.70美元的价格进行570.4283万股普通股的承销公开发行。
该公司预计将从此次发行中筹集约400万美元的总收益，发行计划于2025年7月25日完成。WestPark Capital, Inc.担任本次交易的独家账簿管理人。
iSpecimen计划将净收益中的150万美元用于IR Agency LLC提供的营销和广告服务，以及100万美元用于根据与Sales Stack Solutions Corp.的协议支付初始里程碑款项。剩余资金将用于营运资金和一般公司用途。
此次发行以承诺基础进行，并包括以相同公开发行价格购买普通股的预付权证选项。
iSpecimen运营着一个全球在线市场，连接需要生物样本进行医学研究的科学家与医疗样本提供者网络。
本文由人工智能协助翻译。更多信息，请参见我们的使用条款。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.